Further microarray analyses following KAT6B knockdown revealed a reduction in the expression of a series of genes associated with tumor growth and invasiveness [186], which indicates the oncogenic impact of KAT6B in breast cancer. The gene discussed is KAT6B; the disease is neoplasm.